Chiara Salvetti

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.

Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.

Journal: Cancer immunology, immunotherapy : CII

Published: August 01, 2023

Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights.

Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights.

Journal: Frontiers in oncology

Published: April 10, 2022

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.

Journal: British journal of haematology

Published: December 24, 2021

Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL.

Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL.

Journal: Cancers

Published: April 29, 2021

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.

Journal: Frontiers in immunology

Published: August 13, 2020

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.

Journal: Blood

Published: July 16, 2020

Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation.

Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: March 20, 2020

Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.

Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.

Journal: Cancers

Published: December 20, 2019

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis.

Journal: Cancer medicine

Published: May 07, 2019

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.

Journal: Haematologica

Published: February 01, 2019

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.

ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.

Journal: American journal of hematology

Published: June 19, 2017

Magic pills: new oral drugs to treat chronic lymphocytic leukemia.

Magic pills: new oral drugs to treat chronic lymphocytic leukemia.

Journal: Expert opinion on pharmacotherapy

Published: February 25, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026